Scientists Restore Limited Vision in Blind Patients Using Gene Therapy and Special Goggles
The treatment helped patients pick up objects after three months, but none could yet identify faces, researchers reported.
- In a trial of 10 patients, gene therapy based on 2026 Nobel Prize-winning research partially restored vision in six individuals, researchers reported in The New England Journal of Medicine.
- The treatment uses gene therapy to make retinal cells light-sensitive via the protein ChrimsonR from GenSight Biologics, combined with specialized goggles converting visual information into light patterns to stimulate these cells.
- After three months, six participants could perform tasks like picking up a cup from a table, though they could not distinguish between different people's faces, study leader Dr. José-Alain Sahel of the University of Pittsburgh said.
- "Even in people with profound vision loss, the visual system retains a remarkable capacity to process new information," Sahel said, noting the field's recent Nobel Prize recognition.
- While clinical applications move slowly, researchers believe optogenetics could eventually treat deafness, pain, and epilepsy, expanding the medical potential beyond vision restoration.
16 Articles
16 Articles
Scientists Restore Limited Vision in Blind Patients Using Gene Therapy and Special Goggles
Scientists have demonstrated a promising new approach to restoring limited vision in people with advanced inherited blindness. An experimental treatment combining gene therapy with specialized goggles has helped some people with advanced blindness detect objects and respond to visual cues. Instead of attempting to repair damaged light-sensing cells, the approach gives surviving retinal cells a [...]
Six of the ten participants improved their sensitivity to light. Therapy is still experimental and does not return normal vision, but it is a huge improvement
Blindness treatment based on Nobel-winning research shows promise
Days after the announcement of the Nobel Prize for Medicine in 2026, a clinical trial revealed promising results of an unusual technique that could change the future of blindness treatment, after some patients had recovered the abilities they had lost years ago.
Researchers in Basel are already applying the method awarded the Nobel Prize in Medicine – and are injecting genes into the retina of humans. What is possible with it.
Basel's eye research speaks of a breakthrough in the treatment of the blind. The new form of therapy works.
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
